Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Does Estimated Pulse Wave Velocity Add Prognostic Information? MORGAM Prospective Cohort Project

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Predictive Importance of Blood Pressure Characteristics With Increasing Age in Healthy Men and Women: The MORGAM Project

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Antihypertensive Drugs and Risk of Depression: A Nationwide Population-Based Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Risk of Developing Hypokalemia in Patients With Hypertension Treated With Combination Antihypertensive Therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. FGL1 as a modulator of plasma D-dimer levels: exome-wide marker analysis of plasma tPA, PAI-1 and D-dimer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Response to Roldan et al

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  • MORGAM Project*
Vis graf over relationer

The Reference Values for Arterial Stiffness Collaboration has derived an equation using age and mean blood pressure to estimated pulse wave velocity (ePWV), which predicted cardiovascular events independently of Systematic COoronary Risk Evaluation (SCORE) and Framingham Risk Score. The study aim was to investigate the independent association between ePWV and clinical outcomes in 107 599 apparently healthy subjects (53% men) aged 19 to 97 years from the MORGAM Project who were included between 1982 and 2002 in 38 cohorts from 11 countries. Using multiple Cox-regression analyses, the predictive value of ePWV was calculated adjusting for country of inclusion and either SCORE, Framingham Risk Score, or traditional cardiovascular risk factors (age, sex, smoking, systolic blood pressure, body mass index [BMI], total and high-density lipoprotein cholesterol). Cardiovascular mortality consisted of fatal stroke, fatal myocardial infarction, or coronary death, and the composite cardiovascular end point consisted of stroke, myocardial infarction, or coronary death. Model discrimination was assessed using Harrell's C-statistic. Adjusting for country and logSCORE or Framingham Risk Score, ePWV was associated with all-cause mortality (hazard ratio, 1.23 [95% CI 1.20-1.25] per m/s or 1.32 [1.29-1.34]), cardiovascular mortality (1.26 [1.21-1.32] or 1.35 [1.31-1.40]), and composite cardiovascular end point (1.19 [1.16-1.22] or 1.23 [1.20-1.25]; all P<0.001). However, after adjusting for traditional cardiovascular risk factors, ePWV was only associated with all-cause mortality (1.15 [1.08-1.22], P<0.001) and not with cardiovascular mortality (0.97 [0.91-1.03]) nor composite cardiovascular end point (1.10 [0.97-1.26]). The areas under the last 3 receiver operator characteristic curves remained unchanged when adding ePWV. Elevated ePWV was associated with subsequent mortality and cardiovascular morbidity independently of systematic coronary risk evaluation and Framingham Risk Score but not independently of traditional cardiovascular risk factors.

Udgave nummer6
Sider (fra-til)1420-1428
Antal sider9
StatusUdgivet - jun. 2020

ID: 59691067